OBD is a global biotech company advancing personalized healthcare by developing and commercializing #PrecisionMedicine tests for life-changing diseases.
Oxford, UK
Joined August 2020
- Tweets611
- Following203
- Followers488
- Likes207
Oxford BioDynamics retweeted
Dr Garrett Pohlman presented "Urology Updates” at the Nebraska Academy of Family Physicians conference (#NAFP), highlighting how #EpiSwitchPSE is supporting earlier, high-fidelity #prostatecancer evaluation in everyday practice across #Nebraska.
#OBD #PSE @gpohlmanmd @NEBRAFP
Oxford BioDynamics retweeted
The Sunday Times covered a study using #EpiSwitchOrion, #OBD's AI-enabled discovery platform. @thetimes spoke to Prof Pshezhetskiy of the #UEA Norwich Medical School about the work, and what it could mean for ME/CFS, long COVID, PTSD, RA, MS (paywalled): obdx.co/jej
Oxford BioDynamics retweeted
🎙️ Dr Garrett Pohlman joined Dr Tom Rogers on an episode of The Common Sense MD to discuss why #PSA doesn't tell the full #ProstateCancer story, and how #EpiSwitchPSE adds clarity before biopsy or imaging. youtu.be/Z1vqyGPeHBg
@OxBioDynamics #OBD #PSE #urology @gpohlmanmd
Oxford BioDynamics retweeted
We've partnered with MK Commercial Group, a specialist #lifesciences commercialisation organisation, to extend @OxBioDynamics' US commercial presence and drive growth of #EpiSwitchPSE. Read more: obdx.co/m1t
#OBD #AIM #EpiSwitch #PSE #diagnostics #urology
Oxford BioDynamics retweeted
Honored to join Dr. Drew this evening (4 PM CST / 5 PM EST) on Fox Business Network’s - Dr. Drew’s Health Uncensored to discuss the evolving landscape of #ProstateCancer screening and detection.
Oxford BioDynamics retweeted
This Sunday on @HUwithDrDrew: 3 in 4 raised PSA results aren't #prostatecancer. So what comes next?
—Urologist @gpohlmanmd shares what he's seeing using the breakthrough #EpiSwitchPSE test from @OxBioDynamics #OBD, shown to boost accuracy to 94%. 📺17 May 5pm ET @FoxBusiness #PSE
Oxford BioDynamics retweeted
🎬 Go behind the scenes with @gpohlmanmd in the green room ahead of Health Uncensored with Dr Drew on @FoxBusiness. The national conversation on accurate #prostatecancer testing with #EpiSwitchPSE is about to hit prime time.
📺 Sun 17 May, 5pm ET
@HUwithDrDrew @OxBioDynamics #OBD
Oxford BioDynamics retweeted
Congrats to Doctors Studio on surpassing 400+ #EpiSwitchPSE tests! Under Dr Roy's leadership, Doctors Studio has made patient-centered #prostatecancer care a cornerstone of their practice, with #PSE playing a key role in their ProstaGen Method. @OxBioDynamics #OBD @LisbethRoyDO
Oxford BioDynamics retweeted
🎉750,000 people have watched an independent UK doctor unpack how #EpiSwitchPSE changes #prostatecancer detection. In his viral video, he describes it as "270% Better Than PSA." youtu.be/O360HNAK3fU
Med Man is an independent NHS GP not affiliated with @OxBioDynamics #OBD #PSE
Oxford BioDynamics retweeted
Congratulations to Kearney Urology Center PC on surpassing 400+ #EpiSwitchPSE orders — a strong example of real-world clinical adoption by a urology clinic committed to improving #prostatecancer outcomes.
@OxBioDynamics #OBD #PSE #ProstateCancer #Diagnostics @gpohlmanmd
Oxford BioDynamics retweeted
📣Consultant urologist Mr Winkler shares how the #EpiSwitchPSE is part of #prostatecancer diagnostics at Imperial College Healthcare Private Care, Charing Cross Hospital—a leading prostate cancer centre in London. 🔗mypse.co/i8e
@OxBioDynamics #OBD #PSE #PCAM #urology
Oxford BioDynamics retweeted
Better triage in #ProstateCancer care:
Identify who needs further evaluation—
spare others unnecessary intervention.
Grateful to partners like Jennifer Wright bringing #EpiSwitchPSE into real-world practice.
#OBD #PSE #Urology #PrecisionMedicine
Oxford BioDynamics retweeted
Peer-reviewed physician commentary by urologist @gpohlmanmd—“Reducing Unnecessary Prostate Biopsies Through Real-World Clinical Use of the #EpiSwitchPSE Blood Test”— highlights real-world #PSE use supporting confident patient risk assessment. obdx.co/p8k
#OBD #urology
Oxford BioDynamics retweeted
#PhysicianSpotlight: At #DoctorsStudio, Dr @LisbethRoyDO leads a prostate health program that goes beyond standard screening—with advanced diagnostics, longitudinal monitoring & personalized care. A key component, #EpiSwitchPSE, helps guide her informed #prostatecancer decisions.
Oxford BioDynamics retweeted
Great momentum at #LUGPA2026: @gpohlmanmd delivered the opening talk in the Global Prostate Cancer Congress #AdvancedDiagnostics session to a packed room. He highlighted pathways integrating #EpiSwitchPSE to support smart #prostatecancer care. @OxBioDynamics #urology #PSE #OBD
Oxford BioDynamics retweeted
New blog: “This #ProstateCancer Test is 270% Better Than #PSA”—Med Man Explains #PSE
An #NHS GP & YouTuber explains why #EpiSwitchPSE is “so exciting.” His video hit 470K views in a month.
👉mypse.co/mdm
Note: Med Man is independent & not affiliated with @OxBioDynamics
Oxford BioDynamics retweeted
New on our #blog: the next generation of #cancer testing, in clinic and at home. Less invasive, more accurate options are emerging—but they’re not always talked about. What this means for #earlydiagnosis and better outcomes. 👇
mypse.co/fr7
Oxford BioDynamics retweeted
2 normal MRIs. 2 negative biopsies. 1 aggressive #prostatecancer found with #EpiSwitchPSE.
Standard diagnostics failed a 64yo patient with high #PSA. #PSE guided a 3rd biopsy, revealing Gleason 8 cancer. One blood test, a different outcome. #OBD
👉More at: 94percent.com
Oxford BioDynamics retweeted
A UK doctor has shared an independent clinical overview of the #EpiSwitchPSE test by @OxBioDynamics (#OBD), comparing it with #PSA and highlighting its game-changing accuracy for #ProstateCancer. We appreciate doctors raising awareness for #menshealth. youtube.com/watch?v=O360HNAK…
Oxford BioDynamics retweeted
🚨 Breakthrough in #MECFS research! Join our free webinar “From Mystery to Measurable: The Science Behind the New ME/CFS Blood Test”
🧬Learn how a 96% accurate test could transform diagnosis + treatment.
🗓️ Jan 15, 2026 | 9–10 am PT / 12- 1 pm ET.
🔗ow.ly/aZk450XiOeU
